Healthcare-focused buyout house ArchiMed has scored a 4x return selling Italian healthcare logistics provider Bomi Group to UPS, AltAssets has learned. The post ArchiMed seals 4x return selling Bomi Group to UPS – source first appeared
Healthcare-focused buyout house ArchiMed has agreed to take medical device maker Natus Medical private for $1.2bn. The post ArchiMed to take medical device maker Natus Medical private for $1.2bn first appeared on AltAssets Private Equity News.
Healthcare-focused buyout house ArchiMed has scored a 4x return selling health ingredients developer Fytexia to trade buyer Associated British Foods. The post ArchiMed seals 4x return through Fytexia trade sale, maintains top performance for 2014-vintage buyout fund
Healthcare-focused buyout house ArchiMed has bought into Belgium-based Xpress Biologics to finance a 10x expansion of its production capacity, the firm said. The post ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer
Healthcare-focused buyout house ArchiMed has closed its oversubscribed third fund on €650m despite receiving €1.3bn in the virtual raise. MED III has beat its target of €500m and doubled the size of its predecessor MED
Europe's biggest healthcare private equity investor ArchiMed is expanding in the US through five new appointments in the New York City office.
Healthcare-focused private equity firm ArchiMed has acquired a majority stake in NAMSA, a contract research organisation for medical devices, from the founding Gorski Family.
Healthcare-focused private equity firm ArchiMed has closed its new fund on €1bn, which will target the European and North American mid-cap healthcare sectors.
